about
DNase and atelectasis in non-cystic fibrosis pediatric patientsMucin glycosylation and sulphation in airway epithelial cells is not influenced by cystic fibrosis transmembrane conductance regulator expression.TLR-4-mediated innate immunity is reduced in cystic fibrosis airway cells.Primary Ciliary Dyskinesia: An Update on Clinical Aspects, Genetics, Diagnosis, and Future Treatment StrategiesExpression of the human cystic fibrosis transmembrane conductance regulator gene in the mouse lung after in vivo intratracheal plasmid-mediated gene transfer.Serine proteases degrade airway mucins in cystic fibrosis.Actin filaments mediate DNA fiber formation in chronic inflammatory airway disease.Altered protease and antiprotease balance during a COPD exacerbation contributes to mucus obstruction.The role of recombinant human DNase in the treatment of patients with cystic fibrosis: many promises, more problemsThe role of airway secretions in COPD--clinical applications.Genetics, diagnosis, and future treatment strategies for primary ciliary dyskinesia.Inhaled mannitol in cystic fibrosis.The efficiency of sputum cell counts in cystic fibrosis.Macrorheology of cystic fibrosis, chronic obstructive pulmonary disease & normal sputum.Mutant cystic fibrosis transmembrane conductance regulator inhibits acidification and apoptosis in C127 cells: possible relevance to cystic fibrosis.DNA from bronchial secretions modulates elastase inhibition by alpha(1)-proteinase inhibitor and oxidized secretory leukoprotease inhibitor.Enzymes approved for human therapy: indications, mechanisms and adverse effects.Paper microfluidics for nucleic acid amplification testing (NAAT) of infectious diseases.Macromolecular mechanisms of sputum inhibition of tobramycin activity.Species differences in the physical and transport properties of airway secretions.The pharmacology and toxicology of three new biologic agents used in pulmonary medicine.Aerosolized dornase alfa (rhDNase) for therapy of cystic fibrosis.Neutrophil extracellular traps cause airway obstruction during respiratory syncytial virus disease.DNA concentration and length in sputum of patients with cystic fibrosis during inhalation with recombinant human DNase.Retrospective review of the effects of rhDNase in children with cystic fibrosis.Neutrophil DNA contributes to the antielastase barrier during acute lung inflammation.The disulphide-bond content and rheological properties of intestinal mucins from normal subjects and patients with cystic fibrosisJanus-Faced Neutrophil Extracellular Traps in Periodontitis.Ongoing planned clinical trials investigating the pulmonary management of cystic fibrosis.The role of mucous glycoproteins in the rheologic properties of cystic fibrosis sputum.Markers of mucus secretion and DNA levels in induced sputum from asthmatic and from healthy subjects.MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions.Dornase alfa in early cystic fibrosis lung disease.
P2860
Q21195066-332F1B02-56C4-4EFA-B1F7-AA41AD029D3BQ31144471-305B4251-E754-4B4F-AF7D-D15D785C565FQ33765010-CCAA7B69-ABFA-450F-A400-8A9AD4B3FFA0Q33780616-A08C22CE-8424-4A50-AB09-41E57C7E6EC6Q35072251-933FB412-C3A8-4D02-817B-9261DADD4B7BQ35139399-912B5B30-968D-4AEF-87B8-24C8DE712DDFQ35774309-F4471965-E6BA-40FD-9C0B-BE664C2E84D5Q35848864-5357040C-0C6D-46B5-A16B-DA78C2F2DEAEQ36496558-3F925F48-D9D0-48D1-BC7C-26E9756E1BF5Q36674113-E8A43BA9-5AF1-479A-88D6-FD80C1AC47C5Q36692961-46F87FFD-6909-4E73-99DD-4BEB652BEA75Q36861632-74797412-7AED-48A9-8F9E-5BB703F6D17EQ37177380-CDE7CB4E-D78C-4312-AF81-80A4629F4FEDQ37266356-70375448-ACB7-40A6-BCC5-03C034772349Q37662471-68428784-16D5-4A92-A48E-68F7CC2CB09CQ38307876-87F3B67A-360D-4F84-BFEF-EA1BF44EE6EBQ38342838-20F8AB1B-4F04-4D9C-850B-3BACBE892207Q39385787-45C79034-567F-4890-A3CE-58C6712C6090Q39778842-CC217630-F8C9-42F6-A608-397346B632ECQ40451753-2B38069E-10D1-4660-A979-5135BE94EBA8Q40468781-EA94181B-BAB1-445A-BC3D-D2124112EFFCQ40607441-15BDDD0F-3730-4F5D-A521-D34603E632BCQ40952436-AFE2AD0E-C1C9-4676-8149-C3CCB7D1D2B1Q41231870-C839A7B1-5D4F-4DF2-A77E-924370B6B6BCQ41462524-EE08E082-CEB7-44F6-95F2-3172D49C3259Q42437416-42DF39BA-AC17-4189-9A36-6D5247F60C20Q42793770-28C1E9C7-9E68-4543-B270-B67DA266491DQ43263590-8ADE8B88-419E-40B2-A1D5-48B39C3927D4Q43763396-FE0A0958-2995-492A-8E26-86760C4733E4Q43969323-4C404388-5E8F-4342-8626-FFA9BFEDF2E4Q46345391-0AD7F380-A6A7-4418-9BAD-5A4FAC4DE958Q48014068-51F8AAE7-6C0B-4212-93AF-BAFF70646FEFQ51705669-1D829DD6-C661-45ED-87EE-88BEE2E01DFA
P2860
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年学术文章
@wuu
1978年学术文章
@zh-cn
1978年学术文章
@zh-hans
1978年学术文章
@zh-my
1978年学术文章
@zh-sg
1978年學術文章
@yue
1978年學術文章
@zh
1978年學術文章
@zh-hant
name
Pus, deoxyribonucleic acid, and sputum viscosity.
@ast
Pus, deoxyribonucleic acid, and sputum viscosity.
@en
type
label
Pus, deoxyribonucleic acid, and sputum viscosity.
@ast
Pus, deoxyribonucleic acid, and sputum viscosity.
@en
prefLabel
Pus, deoxyribonucleic acid, and sputum viscosity.
@ast
Pus, deoxyribonucleic acid, and sputum viscosity.
@en
P2093
P2860
P356
P1433
P1476
Pus, deoxyribonucleic acid, and sputum viscosity.
@en
P2093
P2860
P304
P356
10.1136/THX.33.2.235
P407
P577
1978-04-01T00:00:00Z